Share
Economic uncertainty has dampened the anticipated digital health M&A momentum for early 2025, but the sector is still far from stagnant. While larger deals and IPOs have largely paused, there have still been smaller, strategic acquisitions continuing to push forward. This signals that investors are recalibrating—not retreating—and using this phase to strengthen fundamentals and focus on value creation.
In
Modern Healthcare's recent article,
Brad Kuntz, Senior Managing Director, discussed how potential acquirers are seeking for clarity on more volatile aspects such as interest rates and the extent to which businesses will be impacted by tariffs.